Metastatic Bone Tumor
11
1
3
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
18.2%
2 terminated out of 11 trials
66.7%
-19.8% vs benchmark
9%
1 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
Hemiarthroplasty for Elderly With Proximal Humeral Mets
Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
Patterns of Care and Outcomes in Patients With Metastatic Bone Tumors (METABONE)
Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease
Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)
Skeletal Metastasis Registry
Automated Detection of Metastatic Bone Disease on Bone Scintigraphy Scans
ERAS Anesthetic Care for Metastatic Spine Cancer Resection
Length of the Femoral Stem in Arthroplasty Done for Patients With Proximal Femoral Metastatic Lesion
Gemcitabine Plus Ascorbate for Sarcoma in Adults
CTFEA Myeloma Study